# Totaligent and GloMed Solutions sign LOI for joint venture

Totaligent, Inc. and GloMed Solutions LLC signed a binding letter of intent to form a joint venture integrating Totaligent's Aetherium Medical platform with GloMed's operations in Japan and APAC. The JV is expected to close within four weeks, with Totaligent holding strategic control via three board seats.

- Type: Partnership
- Announced: 2026-02-22
- Where: Yokohama, Japan
- Status: announced
- Products: advanced biologics, medical devices, Aetherium Medical platform
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Totaligent](https://endata.com/companies/90462.md) (partner)
- [GloMed Solutions](https://endata.com/companies/90463.md) (partner)

## Sources

- [sec.gov](https://www.sec.gov/Archives/edgar/data/846377/000147793226001016/totaligent_ex101.htm), 2026-02-22: "This Binding Letter of Intent sets forth the binding agreement and understanding between Totaligent, Inc. and GloMed Solutions Limited Liability Company regarding the proposed formation of a joint venture"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.